Representation of Race and Ethnicity in Randomized Clinical Trials of Diabetic Macular Edema and Retinal Vein Occlusion Compared to 2010 US Census Data
- PMID: 36201192
- PMCID: PMC9539735
- DOI: 10.1001/jamaophthalmol.2022.3929
Representation of Race and Ethnicity in Randomized Clinical Trials of Diabetic Macular Edema and Retinal Vein Occlusion Compared to 2010 US Census Data
Abstract
Importance: Diverse enrollment and adequate representation of racial and ethnic minority groups in randomized clinical trials (RCTs) are valuable to ensure external validity and applicability of results.
Objective: To compare the distribution of race and ethnicity in RCTs of diabetic macular edema (DME) and macular edema from retinal vein occlusion (RVO) to that of US Census data.
Design, setting, and participants: This was a cross-sectional retrospective analysis comparing racial and ethnic demographic characteristics of US-based RCTs of DME and RVO between 2004 and 2020 with 2010 US Census data. PubMed and ClinicalTrials.gov were searched to screen for completed phase 3 RCTs with published results. Of 169 trials screened, 146 were excluded because they were incomplete, did not report race and ethnicity, or were not based in the US, and 23 trials were included (15 DME and 8 RVO). The number and percentage of American Indian or Alaska Native, Asian, Black, Hispanic, Native Hawaiian or Other Pacific Islander, and White participants was recorded in each RCT. The demographic distribution and proportion was compared to the reported distribution and proportion in the 2010 US Census using the χ2 test.
Main outcomes and measures: Overrepresentation, underrepresentation, or representation commensurate with 2010 US Census data in the racial and ethnic populations of RCTs of retinal vascular disease.
Results: In 23 included RCTs of DME and RVO, there were a total of 38 participants (0.4%) who identified as American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander (groups combined owing to small numbers), 415 Asian participants (4.4%), 904 Black participants (9.6%), 954 Hispanic participants (10.1%), and 7613 White participants (80.4%). By comparison, the 2010 US Census data indicated that 1.1% of the US population self-reported as American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander (groups combined for comparison in this study), 4.8% self-reported as Asian, 12.6% as Black or African American, 16.3% as Hispanic, and 63.7% as White. American Indian or Alaska Native and Hawaiian or Other Pacific Islander participants were underrepresented in 2 trials, neither overrepresented nor underrepresented in 20, and not overrepresented in any of the included trials. Asian participants were underrepresented in 10 trials, overrepresented in 4, and neither overrepresented nor underrepresented in 8. Black participants were underrepresented in 9 trials, overrepresented in 2, and neither overrepresented nor underrepresented in 11. Hispanic participants were underrepresented in 15 trials, overrepresented in 2, and neither overrepresented nor underrepresented in 5. White participants were underrepresented in 2 trials, overrepresented in 14, and neither overrepresented nor underrepresented in 7. The χ2 values comparing RCT demographic distribution to US 2010 Census data were significantly different in 22 of 23 included RCTs.
Conclusions and relevance: The findings in this study indicated a discrepancy between racial and ethnic demographic data in RCTs of DME and RVO and the US population according to the 2010 Census. White study participants were most frequently overrepresented, and Hispanic study participants were most frequently underrepresented. These findings support the need for more efforts to recruit underrepresented racial and ethnic minorities to improve external validity in trial findings.
Conflict of interest statement
Figures



Comment in
-
Representation Matters-Diversity in Retina Clinical Trials.JAMA Ophthalmol. 2022 Nov 1;140(11):1103-1104. doi: 10.1001/jamaophthalmol.2022.3930. JAMA Ophthalmol. 2022. PMID: 36201217 No abstract available.
Similar articles
-
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640. JAMA Netw Open. 2021. PMID: 33606033 Free PMC article. Review.
-
Racial and Ethnic Distribution in Diabetic Macular Edema Clinical Trials in the United States (2002-2021).Ophthalmol Retina. 2023 Dec;7(12):1035-1041. doi: 10.1016/j.oret.2023.07.015. Epub 2023 Jul 19. Ophthalmol Retina. 2023. PMID: 37479084
-
Clinical Trial Racial and Ethnic Disparities in Minimally Invasive Gynecologic Surgery.J Minim Invasive Gynecol. 2024 May;31(5):414-422. doi: 10.1016/j.jmig.2024.01.019. Epub 2024 Feb 5. J Minim Invasive Gynecol. 2024. PMID: 38325584
-
Race and Ethnicity Representation in Phase 2/3 Oncology Clinical Trial Publications: A Systematic Review.JAMA Health Forum. 2024 Jun 7;5(6):e241388. doi: 10.1001/jamahealthforum.2024.1388. JAMA Health Forum. 2024. PMID: 38848090 Free PMC article.
-
Reporting of Participant Race and Ethnicity in Published US Pediatric Clinical Trials From 2011 to 2020.JAMA Pediatr. 2022 May 1;176(5):e220142. doi: 10.1001/jamapediatrics.2022.0142. Epub 2022 May 2. JAMA Pediatr. 2022. PMID: 35311946 Free PMC article.
Cited by
-
A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX.Front Pharmacol. 2025 Mar 10;16:1516126. doi: 10.3389/fphar.2025.1516126. eCollection 2025. Front Pharmacol. 2025. PMID: 40129946 Free PMC article. Review.
-
Associations between obstructive sleep apnoea and the development and severity of retinal vein occlusion.Eye (Lond). 2025 Jul 16. doi: 10.1038/s41433-025-03900-4. Online ahead of print. Eye (Lond). 2025. PMID: 40670632
-
One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population.Int J Retina Vitreous. 2025 Aug 1;11(1):89. doi: 10.1186/s40942-025-00719-9. Int J Retina Vitreous. 2025. PMID: 40750915 Free PMC article.
-
Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and Enrollment.J Pers Med. 2023 May 23;13(6):880. doi: 10.3390/jpm13060880. J Pers Med. 2023. PMID: 37373869 Free PMC article.
-
Racial, Ethnic, and Gender Diversity in United States Ophthalmology Clinical Trials.Ophthalmol Sci. 2023 Sep 27;4(1):100402. doi: 10.1016/j.xops.2023.100402. eCollection 2024 Jan-Feb. Ophthalmol Sci. 2023. PMID: 38027420 Free PMC article.
References
-
- Bureau UC. The chance that two people chosen at random are of different race or ethnicity groups has increased since 2010. US Census Bureau . Accessed January 1, 2022. https://www.census.gov/library/stories/2021/08/2020-united-states-popula...
-
- Wright PR. Care of culturally diverse patients undergoing ophthalmic surgery. Insight. 2011;36(1):7-10;quiz 11. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical